Semaglutide is a medicine used to slim down in specific patients, as a hypoglycemia drug and also eliminates cardiovascular problems such as? heart attack or stroke in type two diabetes patients thus it comes under the category of anti-diabetic medication and anti-obesity medication.? It was developed by Novo Nordisk in 2012. It is a peptide analogue of GLP-1 with a modification in its side chain.